Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2084026PMC
http://dx.doi.org/10.1136/adc.2007.119909DOI Listing

Publication Analysis

Top Keywords

avidity haemophilus
4
haemophilus influenzae
4
influenzae type
4
type antibody
4
antibody infants
4
avidity
1
influenzae
1
type
1
antibody
1
infants
1

Similar Publications

. Causing approximately 8 million deaths each year, tobacco smoking represents a significant public health concern. Evidence shows that smoking significantly impairs antibody production and immune cell activity following vaccination.

View Article and Find Full Text PDF

Since the introduction of type b (Hib) conjugate vaccines, invasive Hib disease has strongly declined worldwide, yet continued control of Hib disease remains important. In Europe, currently three different hexavalent combination vaccines containing Hib conjugates are marketed. In this phase IV, single-blind, randomized, controlled, multi-country study (NCT04535037), we aimed to compare, in a 2 + 1 vaccination schedule, the immunogenicity and safety and show non-inferiority, as well as superiority, of DTPa-HBV-IPV/Hib (Ih group) versus DTaP5-HB-IPV-Hib (Va group) in terms of anti-polyribosylribitol phosphate (PRP) antibody geometric mean concentrations (GMCs) and proportion of participants reaching anti-PRP antibody concentrations greater than or equal to a threshold of 5 µg/mL.

View Article and Find Full Text PDF

Background: Nontypeable (NTHi) is the most common bacterial otopathogen associated with otitis media (OM). NTHi persists in biofilms within the middle ears of children with chronic and recurrent OM. Australian Aboriginal children suffer exceptionally high rates of chronic and recurrent OM compared to non-Aboriginal children.

View Article and Find Full Text PDF

Selective Capture of Anti-N-glucosylated NTHi Adhesin Peptide Antibodies by a Multivalent Dextran Conjugate.

Chembiochem

February 2022

Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 13, 50019, Sesto Fiorentino, Italy.

Article Synopsis
  • - The study focuses on creating tentacle-like polymers that can enhance the capture of antibodies in patient sera, specifically targeting those found in multiple sclerosis (MS) patients.
  • - Researchers identified a specific peptide epitope from a protein associated with a bacteria (NTHi) that MS antibodies recognize and developed a multivalent dextran conjugate to increase antibody binding.
  • - The new polymer effectively captured both IgG and IgM antibodies from MS patients, demonstrating potential for selectively isolating high-affinity autoantibodies, which could improve diagnostics and treatment for autoimmune conditions.
View Article and Find Full Text PDF

Hyperglucosylated adhesin-derived peptides as antigenic probes in multiple sclerosis: Structure optimization and immunological evaluation.

J Pept Sci

November 2020

Laboratory of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health-Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, Sesto Fiorentino, Italy.

Article Synopsis
  • - Peptides that mimic the specific parts targeted by antibodies can be useful for diagnosing and treating autoimmune diseases like multiple sclerosis (MS) by acting as antigen substitutes.
  • - Research focused on synthesizing peptides derived from the Haemophilus influenzae adhesin, particularly those containing N-linked glucopyranosyl moieties, which were found crucial for strong antibody binding in certain MS patients.
  • - The best-performing synthetic peptide, Ac-KAN (Glc)VTLN (Glc)TT-NH, exhibited effective binding to IgG antibodies, but its binding characteristics didn't rely on the sugar's placement or the peptide's structure in solution, indicating complexity in how these interactions occur.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!